Access to Essential Medicines and International Health Law: Towards a New Paradigm?
College of Law, Prince Mohammad bin Fahd University (Al Khobar, KSA);
摘要
Newly independent countries always expressed the need for an
equal access to essential medicines based on international human
rights treaties. The right to access essential medicines was officially
expressed in 2001 during the World Trade Organization’s
(hereinafter “WTO”) Doha Conference. However, is it possible to
consider that the World Health Organization (hereinafter “WHO”)
has today the prerogatives to coordinate an international response
to a pandemic, facilitate research and development of vaccines and
above all allow fair and equitable access to new treatments? The
recent tensions between the United States and China for instance
demonstrate the structural inertia of both the WHO and the WTO,
and this is all the truer as these key international organizations have
binding rules for States Parties: the International Health
Regulations (2005) adopted by WHO members and the Agreement
on Trade-Related Aspects of Intellectual Property Rights (TRIPS
Agreement) adopted by WTO members. The devastating effects of
the COVID-19 pandemic must encourage the international
community to a change of paradigm by adopting a legally binding
arsenal aimed at facilitating access to essential medicines.
Cooperation with the WHO must be in full conformity with the
purposes and the principles of the Charter of the United Nations which provides that States Parties have a general obligation of
cooperation, including health matters. It is, therefore, essential to
provide the WHO with coercive legal means to ensure compliance
with international treaties and the International Health Regulations.
Abstract
Newly independent countries always expressed the need for an
equal access to essential medicines based on international human
rights treaties. The right to access essential medicines was officially
expressed in 2001 during the World Trade Organization’s
(hereinafter “WTO”) Doha Conference. However, is it possible to
consider that the World Health Organization (hereinafter “WHO”)
has today the prerogatives to coordinate an international response
to a pandemic, facilitate research and development of vaccines and
above all allow fair and equitable access to new treatments? The
recent tensions between the United States and China for instance
demonstrate the structural inertia of both the WHO and the WTO,
and this is all the truer as these key international organizations have
binding rules for States Parties: the International Health
Regulations (2005) adopted by WHO members and the Agreement
on Trade-Related Aspects of Intellectual Property Rights (TRIPS
Agreement) adopted by WTO members. The devastating effects of
the COVID-19 pandemic must encourage the international
community to a change of paradigm by adopting a legally binding
arsenal aimed at facilitating access to essential medicines.
Cooperation with the WHO must be in full conformity with the
purposes and the principles of the Charter of the United Nations which provides that States Parties have a general obligation of
cooperation, including health matters. It is, therefore, essential to
provide the WHO with coercive legal means to ensure compliance
with international treaties and the International Health Regulations.
關鍵詞
- 類型
- 論文
- 期刊
- Asian Journal of WTO & International Health Law and policy
- ISSN
- 1819-5164
- 卷期
- 17卷1期
- 出版
- 2022年03月
- 頁碼
- 175–200
- 編號
- NTUEJ00000066
同期目錄
- Foreword to the Special Issue on “Building a Sustainable Future: New Asian Regionalism in International Economic Law”Pasha L. Hsieh・頁 1–5
- Quantizing Geoeconomics: Emerging Geoeconomics in International Economic Law Through a Quantum WorldviewXinyue Li・頁 5–39
- Current Development of Fisheries Subsidies Regulations After the Failure of WTO Doha Round Negotiations with a Focus on the Asia-Pacific RegionChen-Ju Chen・頁 41–84
- A Critical Appraisal of Initiatives of Asia-Pacific Economic Cooperation (APEC) for the Blue Economy: Deadlocks and Any Possible Way Out?I-Ju Chen・頁 85–113
- Mapping Sustainable Development in Investment Treaties: An Analysis of ASEAN States’ PracticeMark McLaughlin・頁 115–140
- The Inclusion of Anti-Corruption Clauses in International Investment Agreements and Its Possible Systemic ImplicationsYueming Yan・頁 141–173
- Access to Essential Medicines and International Health Law: Towards a New Paradigm?Rabaï Bouderhem・頁 175–200
- Public Health Policy Space for Responding to Potential Pandemics Under the SCM AgreementYing-Jun Lin & Feng-Jen Tsai・頁 201–238
- Shedding Any New Light? The WTO’s Latest Ruling in the US-China Solar BattleMeng (Mandy) Fang・頁 239–277
- A Book Review on Pasha L. Hsieh, “New Asian Regionalism in International Economic Law” (Cambridge University Press, 2021)Yuka Fukunaga・頁 279–286